SightfileU.S. market data from official filings
Companies › CLLS
CELLECTIS S A (CLLS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001627281 · EDGAR filings · Updated 2026-06-26
CELLECTIS S A (CLLS) has 32 institutional managers reporting positions valued at $32.5M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.
Institutional managers
32
Reported 13F value
$32.5M
Data flags
1 active
from SEC filings
Latest updates
- 2026-06-26 — 6-K/A filed
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-11 — Foreign issuer report (6-K) filed
- 2026-06-09 — Foreign issuer report (6-K) filed
- 2026-05-21 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CELLECTIS S A has 32 institutional holders.
Data flags from SEC filings
Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-20 (recurring since 2022-03-03) — source filing. The authoritative details are those stated in the filing itself.
Related companies
CHAMPIONS ONCOLOGY (CSBR) · TSCAN THERAPEUTICS INC (TCRX) · LIFEVANTAGE CORP (LFVN) · CONNECT BIOPHARMA HLDGS LTD (CNTB) · COYA THERAPEUTICS INC (COYA) · COMPUGEN LTD (CGEN)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.